JF
STLN

Jump Financial’s Starling Oncology STLN Stock Holding History

Jump Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.8K Sell
12,300
-104,130
-89% -$437K ﹤0.01% 1928
2026
Q1 		$357K Buy
116,430
+91,151
+361% +$280K ﹤0.01% 1407
2025
Q4 		$90K Sell
25,279
-58,121
-70% -$216K ﹤0.01% 1833
2025
Q3 		$291K Buy
+83,400
New +$286K ﹤0.01% 1503

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jump Financial's STLN Position: Q2 2026 in Review

Jump Financial reduced its Starling Oncology (STLN) stake by 89% in Q2 2026, selling an estimated $437K and leaving 12,300 shares worth $66.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Jump Financial first reported a position in STLN in Q3 2025 and has held it in 4 quarters since. The position peaked at $357K in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Jump Financial held 12,300 shares of Starling Oncology worth $66.8K as of Q2 2026.
  • Jump Financial sold 104,130 Starling Oncology shares in Q2 2026, an estimated $437K.
  • Starling Oncology made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1928 holding.
  • Jump Financial first reported a position in Starling Oncology in Q3 2025 and has held it in 4 quarters since.
  • Jump Financial's Starling Oncology position peaked at $357K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.